Remodeling the microbiome for atherosclerosis therapy
Presented at ACS San Diego 2019 (25—29 August 2019; CA, USA), researchers from The Scripps Research Institute (CA, USA) have developed peptides that can remodel the microbiome of the gut – thus creating a new avenue of therapy for related diseases such as atherosclerosis.
Please sign in or register for FREE
Sign in to RxNet
Not yet a member? Become a member FREE to:
- Get unlimited access to ALL CONTENT
- Read selected articles from journals such as Future Medicinal Chemistry FREE
- Receive a weekly email roundup of the latest news and expert opinions
Did you know?
Your RxNet account also gives you access to communities on regenerative medicine, real-world evidence and 3D printing in medicine. Find out more>>